Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Evoke Pharma (EVOK)

Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Evoke Pharma 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 USA

https://evokepharma.com P: 858-345-1494

Description:

Evoke Pharma, Inc. is a specialty pharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. The Company's lead product candidate, EVK-001, is in late stage clinical testing which is intended for the treatment of diabetic gastroparesis. Evoke Pharma, Inc. is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 4,059
Enterprise Value, $K 4,319
Shares Outstanding, K 8,478
Annual Sales, $ 5,180 K
Annual Net Income, $ -7,790 K
Last Quarter Sales, $ 1,680 K
Last Quarter Net Income, $ -1,990 K
EBIT, $ -7,430 K
EBITDA, $ -7,430 K
60-Month Beta 0.22
% of Insider Shareholders 11.78%
% of Institutional Shareholders 0.00%
Float, K 7,479
% Float 88.22%
Short Volume Ratio 0.46

Growth:

1-Year Return -77.69%
3-Year Return -97.73%
5-Year Return -94.68%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 57.79%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.59 on 03/14/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -2.33
EPS Growth vs. Prev Qtr -15.69%
EPS Growth vs. Prev Year -11.32%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 05/23/22

EVOK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -91.83%
Profit Margin % -150.39%
Debt/Equity -1.94
Price/Sales 0.90
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.77
Interest Coverage -14.58
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar